Best Healthcare Companies in Menlo Park, United States
The 35 best Healthcare companies in Menlo Park, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Synthekine.
Ranked: Best Healthcare companies in Menlo Park
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Synthekine Developer of cytokine therapeutics | $290M | 44 mo ago | Series C | 104 | Debanjan Ray Chief Executive Officer | Top 50M | 290 patents Engineered cytokine and immunoglobulin therapeutics for immune modulation | — |
| 2 | WelbeHealth Provider of comprehensive senior care through PACE programs | $60M | 79 mo ago | Series C | 8 | — | Top 5M | — | — |
| 3 | Health2047 Healthcare consulting services provider | $42M | 100 mo ago | Series B | 28 | Larry Cohen Chief Executive Officer | Top 50M | 25 patents AI-driven empathetic patient dialogue, secure authentication, and health data aggregation platforms. | — |
| 4 | Thefoundry Developer of medical technologies and healthcare companies | $31M | 76 mo ago | Series B | 9 | Hanson Gifford CEO | Top 50M | — | — |
| 5 | Virobay Anti-viral drug discovery and development based on protease inhibitor | $26M | 146 mo ago | Deadpooled | 6 | — | — | 153 patents Cysteine protease inhibitor therapeutics for HCV and neurodegenerative disease | — |
| 6 | TesoRx Pharma Developing novel oral drug delivery platform for unmet medical needs | $23M | 89 mo ago | Series B | 4 | — | — | — | — |
| 7 | Asterias Biotherapeutics Online pharmacy providing affordable generic medications for various health needs | $18M | 139 mo ago | Acquired | 31 | — | — | 154 patents Stem‑cell derived oligodendrocyte progenitor and islet cell therapies for CNS/diabetes | — |
| 8 | SummerBio Manufacturer of diagnostic test kits | $7M | 70 mo ago | Series A | 32 | — | — | — | — |
| 9 | Verantos Provider of data validation and regulatory services to biopharma sector | $7M | 19 mo ago | Funding Raised | 52 | Dan Riskin Chief Executive Officer | Top 10M | 18 patents Medical NLP for term disambiguation and deep phenotyping using machine learning | — |
| 10 | Eclipse Regenesis Designs and develops SBS therapy device 24Funding top 36%Patents top 40%Innovation top 46%Moat bottom 49% All 7 signals ▾Fundingtop 36% Patentstop 40% Innovationtop 46% Moatbottom 49% Talentbottom 49% Globalbottom 35% Marketbottom 14% Funding: Raised $6.2M across 5 rounds · 5 rounds over 6 yrs (0.8/yr) Patents: 9 patents matched (strict assignee match) · 8 filings since 2022 vs 1 in 2017-21 rank vs industry peers · Fliar Intelligence Index 24/100 | $6M | 12 mo ago | Funding Raised | 5 | Thomas Krummel Co-Founder | — | 9 patents Endoscopic gastrointestinal plication and expandable implant delivery systems for organ distention | — |
| 11 | Equify Health Provider of health care services | $2M | 39 mo ago | Funding Raised | — | Sylvie Leotin Founder & CEO | — | — | — |
| 12 | Amaros Provider of AI based ophthalmology clinical trial services | $1M | 18 mo ago | Series A | 7 | — | — | — | — |
| 13 | Charisela Technologies R&D company focused on manufacturing test kits and clinical devices for multiple therapeutic areas | $420K | 190 mo ago | Deadpooled | — | Bob Danielzadeh Founder | — | — | — |
| 14 | VMT Develops & commercialises medical devices and healthcare products | $242K | 194 mo ago | Funding Raised | — | — | — | 33 patents Advanced variable and synchronized gear transmission technologies for mechanical power systems. | — |
| 15 | Mountain View Pharmaceuticals Biopharma company providing PEGylation services for Biopharma companies | $240K | 190 mo ago | Funding Raised | 11 | Merry Sherman President and CEO | — | 132 patents Non-immunogenic enzyme and cytokine polymer conjugates for therapeutic use | — |
Top 12 Healthcare companies in Menlo Park
#1
Funding Raised · Menlo Park, California · founded 2019 · 5 employees$6.2Mraised▾
Designs and develops SBS therapy device
- Sep 2025Grant (prize money)$1.5M
- May 2023Grant (prize money)$970.5K
- Aug 2021Grant (prize money)$1.7M
- Jul 2021Grant (prize money)$1.8M
#2
Funding Raised · Menlo Park, California · founded 2009 · 52 employees$7.2Mraised▾
Provider of data validation and regulatory services to biopharma sector
- Feb 2025Grant (prize money)$5.7M
- 2018Grant (prize money)$1.5M
#3
Series A · Menlo Park, California · founded 2017 · 7 employees$1.3Mraised▾
Provider of AI based ophthalmology clinical trial services
- Mar 2025Series A$1.3M
#4
Series C · Menlo Park, California · founded 2018 · 104 employees$289.5Mraised▾
Developer of cytokine therapeutics
- Jan 2023Series C$100M
- Jun 2021Series B$107.5M
- Sep 2020Series A$82M
#5
Series C · Menlo Park, California · founded 2013 · 8 employees$60Mraised▾
Provider of comprehensive senior care through PACE programs. This organization offers a Program of All-Inclusive Care for the Elderly (PACE), coordinating medical, dental, vision, hearing, in-home care, prescription delivery, transportation, physical therapy, and social activities. Services are typically provided at no cost to eligible seniors. A dedicated team coordinates all aspects of care, ensuring personalized support to help seniors age well at home and in their communities. The program includes access to highly skilled medical professionals.
- Feb 2020Conventional Debt$12M
- Feb 2020Series C$30M
- Jun 2018Series B$15M
- Feb 2017Series A$15M
#6
Series B · Menlo Park, California · founded 1998 · 9 employees$30.8Mraised▾
Developer of medical technologies and healthcare companies. This entity creates and builds companies focused on addressing significant unmet clinical needs. The focus is on developing innovative technologies and therapies that improve patient outcomes. The resulting companies are then supported through various stages of growth and development. The ultimate measure of success is the positive impact on patients' lives.
- Apr 2020Series B$12M
- Feb 2019Series B$15.8M
- Jan 2010Unattributed$3M
#7
Series B · Menlo Park, California · founded 2010 · 4 employees$22.8Mraised▾
Developing novel oral drug delivery platform for unmet medical needs. This is a clinical-stage pharmaceutical company focused on developing new therapeutics using an advanced oral drug delivery platform. The company aims to create breakthrough products in areas where treatment options are limited or suboptimal. They are dedicated to scientific research and development, exploring innovative solutions to address unmet medical needs. The company has a portfolio of products in development and clinical trials, striving to improve patient outcomes through novel drug delivery technologies. Their focus is on creating new products with the potential to transform treatment paradigms.
- Apr 2019Series B$289K
- Jul 2016Series B$697.5K
- Aug 2014Series B$10M
- May 2014Series A$2M
#8
Series B · Menlo Park, California · founded 2015 · 28 employees$42.2Mraised▾
Healthcare consulting services provider
- May 2018Series B$27.2M
- Jan 2016Series A$15M
#9
Deadpooled · Menlo Park, California · founded 2006 · 6 employees$26Mraised▾
Virobay operates as an anti-viral drug discovery and development company. It engages in developing, investigating, and creating treatments for hepatitis C, such as protease and polymerase inhibitors. The pipeline comprises of - VBY-129 (Phase-1) for Pain and Crohn's Disease; VBY-376 (Phase-1) for Fibrosis/NASH; VBY-825 (Phase-Clinical candidate) for Fibrosis/PBC; and Multiple Candidates (Research phase) for Cancer and Alzheimer's. Research and development based on Cathepsin S inhibitor, is underway for Neuropathic Pain, Autoimmune Diseases, Liver Fibrosis and Oncology. Their most advanced product candidate, VBY-891, being developed in partnership with LEO Pharma was scheduled to enter into Phase 2 clinical trials for psoriasis in the third quarter of 2015. The company originally planned to raise $50 million in October 2014 but withdrew its plans for an initial public offering on 31 October 2014.
- Jul 2014Series B$8M
- May 2010Series B$10M
- Dec 2009Conventional Debt$300K
- 2007Series A$8M
#10
Funding Raised · Menlo Park, California · founded 2021$1.8Mraised▾
Provider of health care services
- May 2023Grant (prize money)$1M
- Feb 2021Grant (prize money)$750K
#11
Acquired · Menlo Park, California · founded 2012 · 31 employees$18.3Mraised▾
Online pharmacy providing affordable generic medications for various health needs. It offers a wide range of generic and brand-name medications, focusing on treatments for erectile dysfunction, premature ejaculation, and other health conditions. The company emphasizes discreet shipping, privacy protection, and affordable prices. They provide consultations and support to help customers choose the right medications based on their prescriptions and health needs. The platform aims to offer a convenient and accessible way for individuals to purchase medications online, with a focus on generics from Canada. They offer a cart, login, and customer support. The business model is B2C and offers multiple products and services.
- Feb 2015Post IPO$4M
- May 2014Grant (prize money)$14.3M
#12
Series A · Menlo Park, California · founded 2020 · 32 employees$7.3Mraised▾
Manufacturer of diagnostic test kits
- Nov 2020Series A$7.3M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.